Carol Moreno
MD, PhD
Consultant Haematologist; Head, Haematology Laboratory
👥Biography 个人简介
Carol Moreno is a leading Spanish CLL expert who contributed to pivotal ELEVATE-TN and ELEVATE-RR trials establishing acalabrutinib in treatment-naive and relapsed CLL. Her research evaluated the cardiovascular safety profile of more selective BTK inhibitors compared to ibrutinib, contributing to rational drug selection for patients with cardiovascular comorbidities. She leads the European LeukemiaNet CLL working group and has contributed to consensus treatment guidelines. Her work on CLL biology and prognostication is widely cited internationally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Carol Moreno 的研究动态
Follow Carol Moreno's research updates
留下邮箱，当我们发布与 Carol Moreno（Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment